Profile
Brian D.
Morgan is currently a Director at Scottish Biomedical, a Member at The Royal Society of Chemistry, and a Member at the Institute of Biology.
In the past, he was a Director-Supervisory Board at ProtAffin Biotechnologie AG from 2009 to 2014, a Member-Supervisory Board at 4SC AG in 2008, and a Principal at GSK Plc.
Brian D. Morgan active positions
| Companies | Position | Start |
|---|---|---|
Scottish Biomedical
Scottish Biomedical Miscellaneous Commercial ServicesCommercial Services Biological research | Director/Board Member | - |
The Royal Society of Chemistry
The Royal Society of Chemistry Miscellaneous Commercial ServicesCommercial Services Professional organization for the chemical sciences | Corporate Officer/Principal | - |
Institute of Biology | Corporate Officer/Principal | - |
Former positions of Brian D. Morgan
| Companies | Position | End |
|---|---|---|
ProtAffin Biotechnologie AG
ProtAffin Biotechnologie AG Pharmaceuticals: MajorHealth Technology Develops anti-inflammatory products | Director/Board Member | 2014-02-16 |
| 4SC AG | Director/Board Member | 2008-06-04 |
| GSK PLC | Corporate Officer/Principal | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
4SC AG
4SC AG BiotechnologyHealth Technology Develops drugs for cancer treatment | Health Technology |
GSK Plc
GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Scottish Biomedical
Scottish Biomedical Miscellaneous Commercial ServicesCommercial Services Biological research | Commercial Services |
The Royal Society of Chemistry
The Royal Society of Chemistry Miscellaneous Commercial ServicesCommercial Services Professional organization for the chemical sciences | Commercial Services |
ProtAffin Biotechnologie AG
ProtAffin Biotechnologie AG Pharmaceuticals: MajorHealth Technology Develops anti-inflammatory products | Health Technology |
Institute of Biology |
- Stock Market
- Insiders
- Brian D. Morgan
















